LEVOTHYROXINE SODIUM
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | LEVOTHYROXINE SODIUM |
| DrugBank ID | DB00451 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 17 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| differentiated thyroid carcinoma | TxGNN Knowledge Graph | L5 |
| thyroid gland disease | TxGNN Knowledge Graph | L5 |
| familial thyroid carcinoma | TxGNN Knowledge Graph | L5 |
| goiter, multinodular 1, with or without sertoli-leydig cell tumors | TxGNN Knowledge Graph | L5 |
| congenital hypothyroidism | TxGNN Knowledge Graph | L5 |
| hypothyroidism | TxGNN Knowledge Graph | L5 |
| thyroid cancer | TxGNN Knowledge Graph | L5 |
| endemic goiter | TxGNN Knowledge Graph | L5 |
| myxedema | TxGNN Knowledge Graph | L5 |
| substernal goiter | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11